Stay updated on XmAb®18087 in NET and GIST Clinical Trial
Sign up to get notified when there's something new on the XmAb®18087 in NET and GIST Clinical Trial page.

Latest updates to the XmAb®18087 in NET and GIST Clinical Trial page
- Check6 days agoChange DetectedThe page now displays a government funding lapse notice and a version update (Revision: v3.4.1), replacing the prior version (v3.4.0); These changes do not modify core study content such as the study data, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check13 days agoChange DetectedThe changes are limited to page metadata and UI elements (Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0) and do not modify core trial details such as eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision note updated from v3.3.3 to v3.3.4; the page footer now displays the revised version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedA new 'Locations' section lists all study sites by state (Arizona, California, Colorado, Florida, Georgia, Illinois, Massachusetts, Minnesota, New York, Ohio, Pennsylvania, Texas, and Virginia). The old state-specific location headings were removed, and a footer entry shows Revision: v3.3.3.SummaryDifference2%

- Check77 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2, affecting only metadata; there are no changes to study content, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoved the government funding and operating status notice from the page, which warned users about potential delays and updates. This change does not affect the study details, eligibility criteria, endpoints, or other core information presented.SummaryDifference0.4%

Stay in the know with updates to XmAb®18087 in NET and GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®18087 in NET and GIST Clinical Trial page.